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a b s t r a c t
A variety of both RNA and DNA viruses envelop their capsids in a lipid bilayer. One of the more recently
appreciated beneﬁts this envelope is incorporation of phosphatidylserine (PtdSer). Surface exposure of
PtdSer disguises viruses as apoptotic bodies; tricking cells into engulﬁng virions. This mechanism is
termed apoptotic mimicry. Several PtdSer receptors have been identiﬁed to enhance virus entry and we
have termed this group of proteins PtdSer-mediated virus entry enhancing receptors or PVEERs. These
receptors enhance entry of a range of enveloped viruses. Internalization of virions by PVEERs provides a
broad mechanism of entry with little investment by the virus itself. PVEERs may allow some viruses to
attach to cells, thereby making viral glycoprotein/cellular receptor interactions more probable. Alter-
natively, other viruses may rely entirely on PVEERs for internalization into endosomes. This review
provides an overview of PtdSer receptors that serve as PVEERs and the biology behind virion/PVEER
interaction.
& 2014 Elsevier Inc. All rights reserved.
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Introduction
A variety of both RNA and DNA viruses envelop their capsids
in a lipid bilayer. This outer membrane is obtained during virus
budding from either plasma or organelle membranes. While
reliance on an envelope sensitizes viruses to desiccation, deter-
gents, and heat, these envelopes provide a number of beneﬁts for
the virus, including protection of viral structural proteins from
immune recognition and neutralizing antibodies, a platform for
displaying viral proteins, a barrier to enclose viral and cellular
proteins necessary for early steps during infection, and a mechan-
ism for virus egress without lysing infected cells. In addition,
a more recently appreciated beneﬁt is the incorporation of
phospholipids into viral envelopes. Presentation of phosphatidyl-
serine (PtdSer) on the outer leaﬂet of these membranes disguises
viruses as apoptotic bodies, thereby conning cells into engulﬁng
virions through cell clearance mechanisms. This mechanism of
enhanced virus entry is termed apoptotic mimicry.
Over the past three years, receptors and receptor complexes
have recently been identiﬁed that enhance entry of a diverse range
of enveloped viruses. This group of viral receptors shares the
ability to bind to PtdSer present on the viral envelope and,
consequently, we have termed them PtdSer-mediated virus entry
enhancing receptors or PVEERs. The broad expression of these
receptors and their ability to interact with PtdSer on a wide array
of enveloped viruses has huge potential implications for virus
infection. Most importantly, PVEERs enhance virus binding to cells
and facilitate internalization. These receptors also contribute to
immune evasion through both anti-inﬂammatory signaling and a
mechanism of entry that does not require extracellular exposure of
key receptor-binding domain and fusion epitopes. In this review
we summarize what is known about the identiﬁed PVEERs and
their role in virus entry and identify important gaps in current
knowledge.
History of PVEER discovery
Apoptotic mimicry was ﬁrst hypothesized to be used by hepatitis B
virus (Vanlandschoot and Leroux-Roels, 2003), but was experimen-
tally conﬁrmed with vaccinia virus (Mercer and Helenius, 2008).
Inactivation of vaccinia virus by NP-40-mediated lipid depletion could
be rescued by incubation with PtdSer liposomes (Oie, 1985). However,
the contribution of PtdSer to infection was not understood. Mercer
et al. furthered these studies and determined that not only PtdSer is
present on the surface of some vaccinia infectious particles, but
Annexin V (AnxV), a PtdSer-binding protein, can bind to PtdSer on
viral envelopes and inhibit vaccinia infection (Mercer and Helenius,
2008). These results were conﬁrmed by another study that found
substitutionwith a non-biologically relevant isomer of PtdSer restored
infectivity (Laliberte and Moss, 2009). In addition, a role for viral
envelope PtdSer during infectionwas demonstrated for Pichinde virus
and HIV-1 (Soares et al., 2008; Callahan et al., 2003).
A protein complex composed of growth-arrest-speciﬁc 6 (Gas6)
and the tyrosine kinase receptor, Axl, was the ﬁrst set of cellular
proteins to be implicated in PtdSer-binding enhancement of viral
entry (Morizono et al., 2011). It was shown that the soluble protein
Gas6 binds to PtdSer on the virion surface and bridges virus to the
cell surface via interaction with the tyrosine kinase receptor,
Axl and formation of this complex is necessary for enhancement
of virus entry. This study found in addition to vaccinia virus, the
Gas6/Axl complex enhances binding and entry of lentiviruses
pseudotyped with Ross River GP, baculovirus GP64, or Sindbis
env, demonstrating for the ﬁrst time that PtdSer binding can
enhance entry of viral particles bearing a variety of different viral
glycoproteins. More recently, a variety of additional PVEERs were
identiﬁed, including T-cell immunoglobulin and mucin domain 1
and 4 (TIM-1 and 4) proteins and MFG-E8/integrin αvβ3 or αvβ5
complexes (Meertens et al., 2012; Jemielity et al., 2013; Moller-
Tank et al., 2013; Morizono and Chen, 2014). The details of virion
interactions with different PVEERs are highlighted below.
Several recent studies have expanded our understanding of
PVEERs. The group of viruses whose entry is enhanced by PVEERs
now include members of the ﬂavivirus, ﬁlovirus, New World
arenavirus, baculovirus, and alphavirus families (Meertens et al.,
2012; Jemielity et al., 2013; Moller-Tank et al., 2013; Morizono and
Chen, 2014). Between viruses within these families, the extent to
which PVEERs enhance virus entry varies, but generally viruses do
not appear to utilize one PVEER effectively and not another. This
suggests that virion uptake mediated by the different PVEERs is
mechanistically similar. Despite the strong evidence that PVEERs
interact with virion associated PtdSer, the utilization of PVEER-
dependent virus entry is inﬂuenced by the viral glycoprotein
presence on the virion. For instance, entry of viruses bearing the
envelope proteins of Old World arenaviruses, coronaviruses,
inﬂuenza A virus, vesicular stomatitis virus, or herpes simplex
virus 1 is not enhanced by PVEER expression (Morizono et al.,
2011; Meertens et al., 2012; Jemielity et al., 2013; Moller-Tank et
al., 2013; Kondratowicz et al., 2011). Thus, while PVEERs do not
enhance entry all enveloped viruses, they do represent a poten-
tially important class of receptors for a large and diverse collection
of important human pathogenic viruses.
Characterization of identiﬁed PVEERs
Six PVEERs have been identiﬁed to date: TIM-1, TIM-4, Gas6 or
Protein S/Axl, Mer, and Tyro3, and MFG-E8/integrin αvβ3 and
αvβ5. A summary of characteristics of these PVEERs is shown
in Table 1. The key property that these proteins or complexes
utilize to enhance virus entry is their ability to bind PtdSer and a
native function of all of these receptors is to bind and clear
apoptotic bodies (Ravichandran, 2011). Mutation of residues
involved in PtdSer binding or complex formation results in
inhibition of PVEER function (Morizono et al., 2011; Meertens
et al., 2012; Moller-Tank et al., 2013; Morizono and Chen, 2014).
Further, competition with PtdSer liposomes, but not phosphati-
dylcholine liposomes, inhibits entry enhancement by PVEERs
(Jemielity et al., 2013; Moller-Tank et al., 2013). Phosphatidyletha-
nolamine liposomes are also somewhat inhibitory, likely due to
sharing similar structure to PtdSer (Jemielity et al., 2013). In some
cases, prebinding virus with the PtdSer-binding protein, Annexin V
(AnxV), has been shown to inhibit PVEER enhancement of entry
(Mercer and Helenius, 2008; Callahan et al., 2003; Meertens et al.,
2012), but not in others (Morizono and Chen, 2014). Consistent
with the ability of an array of PtdSer receptors to serve as PVEERS,
an artiﬁcially generated PVEER containing the PtdSer-binding
domain from AnxV was highly effective at mediating uptake of
vesicular stomatitis virus (VSV) pseudovirions bearing a ﬁlovirus,
alphavirus or baculovirus glycoprotein (Moller-Tank et al., 2014).
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Table 1
PtdSer receptors: distribution and efﬁcacy as a viral receptor.
Protein name (s) PtdSer binding
domain
Tissue/cell type expression Pseudoviruses for which entry is
enhanced (42 fold)
Pseudoviruses for which entry is
unaffected (o2 fold)
Cell lines reported to express PtdSer
receptor
TIM-1 IgV(Kobayashi et al.,
2007)
Immune cells: Filovirus: Old World Arenavirus: Human:
B cells (Sizing et al., 2007), mast cells (Nakae et al., 2007),
TH2 CD4þ T cells (Meyers et al., 2005; Umetsu et al., 2005;
Khademi et al., 2004), and NKT cells (Lee et al., 2010; Kim et
al., 2013)
Ebola● and Marburg (Jemielity et al.,
2013; Moller-Tank et al., 2013;
Kondratowicz et al., 2011)
Lassa Virus, LCMV (Jemielity et al., 2013;
Moller-Tank et al., 2013)
Huh-7, ACHN, A498, 786-O, Caco-2,
CAKI-1, TK-10, UO-3, Vero, A549, Cos-
7 (Meertens et al., 2012;
Kondratowicz et al., 2011)
Epithelial cells: Alphavirus: New World Arenavirus:
Kidney (Kondratowicz et al., 2011; Ichimura et al., 1998) and
airway and eye mucosa (Kondratowicz et al., 2011)
Ross River●, Chikungunya, Sindbis●,
Eastern Equine Encephalitis (Jemielity
et al., 2013; Moller-Tank et al., 2013;
Morizono and Chen 2014)
Oliveros (Jemielity et al., 2013)
Baculovirus: Inﬂuenza A virus:
Autographa californica multicapsid
nucleopolyhedrovirus● (Moller-Tank et
al., 2013)
H7N1, H1N1● (Jemielity et al., 2013)
Rhabdovirus: Coronavirus:
Vesicular stomatitis virus (Morizono
and Chen, 2014)
SARS (Jemielity et al., 2013)
New World Arenavirus: Rhabdovirus:
Amapari, Tacaribe●, Junín, and
Machupo virus (Jemielity et al., 2013)
Vesicular stomatitis virus (Jemielity et
al., 2013)
Flavivirus: Herpes simplex virus:
West Nile Virus●, Dengue●, Yellow
Fever virus● (Meertens et al., 2012;
Jemielity et al., 2013)
HSV-1● (Meertens et al., 2012)
TIM-3 IgV(DeKruyff et al.,
2010)
Immune cells: Flavivirus: Alphavirus: Mouse:
TH1 and TH17 CD4þ T cells (Khademi et al., 2004; Hastings
et al., 2009; Monney et al., 2002; Nakae et al., 2007), mast
cells (Nakae et al., 2007), DCs (DeKruyff et al., 2010;
Anderson et al., 2007), and monocytes (Anderson et al.,
2007)
West Nile Virus, Dengue Virus●
(Meertens et al., 2012; Jemielity et al.,
2013)
Sindbis (Morizono and Chen, 2014) Raw264.7 (DeKruyff et al., 2010)
Epithelial cells: New World Arenavirus: Filovirus: Human:
Bronchial (DeKruyff et al., 2010) Tacaribe (Jemielity et al., 2013) Ebola, Marburg (Jemielity et al., 2013) PMA stimulated THP-1 cells (DeKruyff
et al., 2010)
Old World Arenavirus:
LASV, LCMV (Jemielity et al., 2013)
New World Arenavirus:
Tacaribe, Junín, Machupo, Oliveros
(Jemielity et al., 2013)
Inﬂuenza A virus:
H7N1 (Jemielity et al., 2013)
Rhabdovirus:
Vesicular stomatitis virus (Jemielity et
al., 2013)
TIM-4 IgV(Kobayashi et al.,
2007; Santiago et
al., 2007; Miyanishi
et al., 2007)
Immune cells: Filovirus: New World Arenavirus:
Macrophages and mature DCs (Kobayashi et al., 2007;
DeKruyff et al., 2010; Miyanishi et al., 2007; Mizui et al.,
2008; Meyers et al., 2005), and B-1 cells (Rodriguez-
Manzanet et al., 2010)
Ebola, Marburg (Jemielity et al., 2013;
Moller-Tank et al., 2013)
Oliveros (Jemielity et al., 2013)
Tissues: Alphavirus: Old World Arenavirus:
Spleen, lymph node, and peritoneum (Miyanishi et al., 2007;
Meyers et al., 2005)
Sindbis, Ross River (Morizono and Chen,
2014), Eastern Equine Encephalitis
(Jemielity et al., 2013)
LASV, LCMV (Jemielity et al., 2013)
New World Arenavirus: Inﬂuenza A virus:
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Table 1 (continued )
Protein name (s) PtdSer binding
domain
Tissue/cell type expression Pseudoviruses for which entry is
enhanced (42 fold)
Pseudoviruses for which entry is
unaffected (o2 fold)
Cell lines reported to express PtdSer
receptor
Tacaribe, Junín, Machupo (Jemielity et
al., 2013)
H7N1 (Jemielity et al., 2013)
Baculovirus: Herpes simplex virus:
Autographa californica multicapsid
nucleopolyhedrovirus (Morizono and
Chen, 2014)
HSV-1● (Meertens et al., 2012)
Rhabdovirus:
Vesicular stomatitis virus (Jemielity et
al., 2013)
Flavivirus:
West Nile Virus●, Dengue●, Yellow
Fever virus● (Meertens et al., 2012;
Jemielity et al., 2013)
TAM ligand
(Protein S or
Gas6) / TAM
receptor
kinases (Tyro3,
Mer, or Axl)
Gla(Huang et al.,
2003; Rajotte et al.,
2008) domain of
TAM ligand
Reviewed here: (Lemke and Rothlin, 2008) Filovirus: Old World Arenavirus: Human:
Blood cells: Ebola, Marburg (Jemielity et al., 2013;
Shimojima et al., 2006)
LASV, LCMV (Jemielity et al., 2013) A549, Vero, Cos-7, HeLa, SNB19, and
SN12C (Meertens et al., 2012;
Shimojima et al., 2006; Brindley et al.,
2011)
Platelets (Angelillo-Scherrer et al., 2001) Rhabdovirus: New World Arenavirus:
Immune cells: Vesicular stomatitis virus (Morizono
and Chen, 2014)
Machupo (Jemielity et al., 2013),
Macrophages, NK cells, NKT cells, and DCs (Seitz et al., 2007;
Caraux et al., 2006; Behrens et al., 2003)
Baculovirus: Oliveros (Jemielity et al., 2013)
Connective tissue: Autographa californica multicapsid
nucleopolyhedrovirus (Morizono et al.,
2011; Morizono and Chen, 2014)
Rhabdovirus:
Bone marrow stromal cells (Caraux et al., 2006) Alphavirus: Vesicular stomatitis virus (Jemielity et
al., 2013)
Tissues: Sindbis, Ross River (Morizono et al.,
2011; Morizono and Chen, 2014)
Inﬂuenza A virus:
Testes (Lu et al., 1999; Wang et al., 2005), CNS (Stitt et al.,
1995; Prieto et al., 2000), retina (Prasad et al., 2006), and
foreskin ﬁbroblasts (Brindley et al., 2011)
Pox virus: H7N1 (Jemielity et al., 2013)
Vaccinia Virus● (Morizono et al., 2011) Herpes simplex virus:
New World Arenavirus: HSV-1● (Meertens et al., 2012)
Amapari, Tacaribe, Junín (Jemielity et
al., 2013)
Alphavirus:
Chikingunya, Eastern Equine
Encephalitis (Jemielity et al., 2013)
Flavivirus:
Dengue● (Meertens et al., 2012)
MFG-E8/ αvβ3-5
integrin
C2 domain
(Andersen et al.,
2000; Ye et al.,
2013)
Immune cells: Alphavirus: Rhabdovirus: Human:
Macrophages (Hanayama et al., 2002; Hanayama et al.,
2004; Finnemann and Rodriguez-Boulan, 1999; Antonov et
al., 2004), Immature DCs (Miyasaka et al., 2004; Albert et al.,
1998)
Ross River and Sindbis (Morizono and
Chen, 2014)
Vesicular stomatitis virus (Morizono
and Chen, 2014)
HEC-1A, Ishikawa, HEEC, K562, HL60
(Bocca et al., 2012; Kruger et al.,
2000);
Tissues: Baculovirus: Mouse:
Mammary glands (Oshima et al., 1999; Stubbs et al., 1990),
spleen, lymph node, brain (Hanayama et al., 2004; Garmy‐
Susini et al., 2007; Uehara and Uehara, 2014), and vascular
system (Silvestre et al., 2005; Brooks et al., 1994)
Autographa californica multicapsid
nucleopolyhedrovirus (Morizono and
Chen, 2014)
COMMA-1D, D1, P388D1(Hanayama
et al., 2004; Thery et al., 1999; Oshima
et al., 2002)
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CD300a IgV (Simhadri et al.,
2012)
Immune cells: Alphavirus: Alphavirus: Human:
CD8þ T cells (Xu et al., 2012), CD4þ T cells (Clark et al.,
2007; Simhadri et al., 2011; Narayanan et al., 2010), B cells
(Silva et al., 2011), and NK cells (Lankry et al., 2010; Cantoni
et al., 1999)
Sindbis (Morizono and Chen, 2014)●● Ross River and Sindbis (Morizono and
Chen, 2014)
THP1, U937, REC-1, SUDHL5, 721.221
(Silva et al., 2011; Kim et al., 2012)
Baculovirus:
Autographa californica multicapsid
nucleopolyhedrovirus (Morizono and
Chen, 2014)
Rhabdovirus:
Vesicular stomatitis virus (Morizono
and Chen, 2014)
BAI1 Type
1 thrombospondin
repeats (TSRs) (Park
et al., 2007)
Tissues: Alphavirus: Human:
Brain (Shiratsuchi et al., 1997; Sokolowski et al., 2011),
muscle(Hochreiter-Hufford et al., 2013), bone marrow, and
spleen (Park et al., 2007)
Ross River and Sindbis (Morizono and
Chen, 2014)
J774 and RAW264.7 (Park et al., 2007)
Immune cells: Baculovirus:
Macrophages (Park et al., 2007) Autographa californica multicapsid
nucleopolyhedrovirus (Morizono and
Chen, 2014)
Rhabdovirus:
Vesicular stomatitis virus (Morizono
and Chen, 2014)
Flavivirus:
Dengue● (Meertens et al., 2012)
RAGE IgV (Friggeri et al.,
2011)●●●
Immune cells: Old World Arenavirus: Human:
CD8þ and CD4þ T cells (Akirav et al., 2012; Moser et al.,
2007), DCs (Dumitriu et al., 2005), macrophages (Zhang et
al., 2009; Sunahori et al., 2006), and monocytes (Ohashi et
al., 2010)
Lassa (Moller-Tank et al., 2013) HaCaT (Zhu et al., 2012), A549
(Nakano et al., 2006)
Tissues: Filovirus:
Smooth muscle (Zhang et al., 2009; Kamioka et al., 2011), Ebola virus (Moller-Tank et al., 2013)
cartilidge chondrocytes (Loeser et al., 2005), skin
keratinocytes (Zhu et al., 2012), and vascular system
(Pollreisz et al., 2010; Liu et al., 2010)
Stabilin-1/-2 Epidermal growth
factor-like domain
(Park et al., 2009,
2008; Kim et al.,
2010)
Immune cells: Alphavirus: Human:
Macrophages (Park et al., 2008, 2009; Martens et al., 2006) Ross River and Sindbis (Morizono and
Chen, 2014)
PMA stimulated THP1(Park et al.,
2008)
Tissues: Baculovirus: Mouse:
Sinusoidal endothelial cells (Martens et al., 2006; Falkowski
et al., 2003), spleen, lymph node, liver, bone marrow,
cornea, brain, heart, and kidney (Falkowski et al., 2003;
Goerdt et al., 1991)
Autographa californica multicapsid
nucleopolyhedrovirus (Morizono and
Chen, 2014)
PMA stimulated P388D1 cells (Park et
al., 2008)
Rhabdovirus:
Vesicular stomatitis virus (Morizono
and Chen, 2014)
●Conﬁrmed using infectious virus.
●●Enhances binding only, but not infection.
●●●Hypothesized but not shown
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Recent studies have demonstrated that virus internalization into
HEK 293T cells can occur entirely independently of the presence of a
viral glycoprotein. This virion internalization is signiﬁcantly enhanced
by PVEER overexpression and is inhibited by competition with PtdSer
liposomes (Jemielity et al., 2013; Moller-Tank et al., 2013), providing
compelling evidence that virion associated PtdSer/PVEER interactions
are responsible for virion uptake, not just virus binding. While the
cellular compartment(s) into which PVEERs deliver virions has yet to
be identiﬁed, indirect evidence indicates that uptake of cargo is into
endosomes (Kobayashi et al., 2007; Albacker et al., 2010). Once the
virion is internalized, the presence of a viral glycoprotein on the virion
is necessary for fusion events with the endosomal membrane. An
overview of each group of PVEERs is given below.
TIM-1 and TIM-4
TIM-1 was ﬁrst implicated in enveloped virus entry as a speciﬁc
receptor for ﬁloviruses (Kondratowicz et al., 2011). However, it was
later discovered that both TIM-1 and family member, TIM-4, enhance
virus entry as PVEERs through binding of PtdSer (Meertens et al.,
2012; Jemielity et al., 2013; Moller-Tank et al., 2013). The human TIM
family members are type I, cell-surface glycoproteins that along with
their murine counterparts, share a common structure. Their amino
terminal immunoglobulin variable (IgV)-like domain extends from
the plasma membrane by a heavily O-linked-glycosylated mucin-like
domain (MLD), which is attached to the cell surface by a transmem-
brane domain followed by a cytoplasmic tail (Fig. 1) (McIntire et al.,
2004). TIM-1 signals through phosphorylation of cytoplasmic tail
tyrosines (Binne et al., 2007; de Souza et al., 2005, 2008); however,
none of the TIM family members require their cytoplasmic domains
for PVEER function (Meertens et al., 2012; Moller-Tank et al., 2014).
TIM-1 and TIM-4 are unique among PVEERs as their PtdSer-
binding domains are a portion of a transmembrane protein rather
than an independent, small protein that binds to a plasmamembrane
receptor. The PtdSer-binding pocket is located between two loops of
the IgV domain (Fig. 2) (Kobayashi et al., 2007; Santiago et al., 2007;
DeKruyff et al., 2010; Miyanishi et al., 2007). Conserved aspartate and
asparagine residues within the upper loop are involved in coordina-
tion of a cation that, in conjunction with residues of the lower loop,
form hydrogen bonds with the phosphate and serine groups of
PtdSer (Santiago et al., 2007). This PtdSer binding is necessary for the
native functions of TIM-1 and TIM-4: apoptotic body clearance and
immune cell regulation (Albacker et al., 2010; Miyanishi et al., 2007;
Lee et al., 2010; Kim et al., 2013; Ichimura et al., 2008; Rodriguez-
Manzanet et al., 2010; Mizui et al., 2008; Wong et al., 2010). Mutation
of aspartate and/or asparagine or chelation of free cations with EGTA
results in signiﬁcant loss in PtdSer binding and subsequent PVEER
efﬁcacy (Meertens et al., 2012; Moller-Tank et al., 2013). A recent
study suggests TIM-4 is more sensitive than TIM-1 or -3 to differ-
ences in membrane-PtdSer concentrations due to additional PtdSer-
binding residues outside of the pocket (Tietjen et al., 2014). This
altered sensitivity may have implications for virus binding.
While all human TIM family members can bind PtdSer and
enhance the uptake of apoptotic bodies (Kobayashi et al., 2007;
DeKruyff et al., 2010), TIM-3 does not effectively enhance virus entry
(o2 fold) (Meertens et al., 2012; Jemielity et al., 2013; Kondratowicz
et al., 2011). Though the IgV domain of TIM-3 has reduced afﬁnity for
PtdSer (DeKruyff et al., 2010), replacing the TIM-1 or TIM-4 IgV
domainwith that of TIM-3 results in a functional PVEER (Moller-Tank
et al., 2014). Thus, the reduced efﬁcacy is not due to the TIM-3 IgV
domain. Rather, the inability of TIM-3 to function effectively as a
PVEER is likely due to the short length of the TIM-3 MLD which is
2.5-fold shorter than that of TIM-1 and -4 (Fig. 1). This is supported
by studies showing that deletions within the MLD of TIM-1 reduce
PVEER efﬁcacy (Jemielity et al., 2013; Moller-Tank et al., 2014).
Protein S and Gas6/Tyro3, Axl, and Mer
Tyro3, Axl, and Mer (TAM) are members of the TAM family of
receptor tyrosine kinases. These highly related proteins contain
two N-terminal immunoglobulin-like domains, followed by two
ﬁbronectin type III domains, a single transmembrane domain, and
a cytoplasmic protein tyrosine kinase (PTK) domain (Fig. 2). TAM
N-terminal interaction with Gas6 leads to activation of the TAM
receptors and autophosphorylation of tyrosines within the PTK
domain (Stitt et al., 1995). Tyro3 and Mer, but not Axl, are similarly
activated by binding Protein S (Stitt et al., 1995; Prasad et al.,
2006). Both Gas6 and Protein S consist of an N-terminal domain
rich in γ-carboxyglutamic acid residues (Gla) that binds to PtdSer
(Fig. 1) (Huang et al., 2003; Ishimoto et al., 2000; Rajotte et al.,
2008), a loop region, four epidermal growth factor-like repeats,
and two C- terminal laminin G-like domains forming a sex
Fig. 1. PtdSer-binding receptors that function as PVEERs. Cartoon representations of Gas 6/Axl (representatives of TAM ligand and receptor kinases), TIM-1, TIM-4, and
MFG-E8/ αvβ3 integrin are displayed. Estimations of N-linked glycan sites are represented as blue tridents and O-link glycoslyations (TIM-1 and TIM-4 only) are shown as
green lines. Domains for which calcium-binding is necessary for interaction with PtdSer are indicated with calcium ions (orange spheres). Gas6 and Axl interact through their
respective laminin G-like and IgC2 domains. MFG-E8 contains an Arg-Gly-Asp (RGD) motif in the second EGF domain that likely binds at the interface of the αvβ3/5 integrin
complex (Xiong et al., 2002).
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hormone-binding globulin-like structure that binds to the Ig-like
domains of the TAM receptors (Sasaki et al., 2006, 2002). Dimer-
ization of TAM receptors occurs after binding of their ligands,
resulting in a 2:2 complex, and is necessary for signaling (Sasaki
et al., 2006).
All TAM receptors in combination with their Gas6 or Protein S
ligand have been shown to effectively enhance virus entry, although
studies suggest that the relative effectiveness of the three TAM
members as PVEERs varies (Morizono et al., 2011; Meertens et al.,
2012; Jemielity et al., 2013; Bhattacharyya et al., 2013). This may be
due to differences in binding afﬁnities between the TAM receptors and
their ligands (Nagata et al., 1996) or relative expression. As the PtdSer-
binding activity of PVEERs is essential for efﬁcacy, in the case of the
TAM receptors, this occurs through the Gla domain of Gas6/Protein S
and removal of this domain eliminates PVEER function of the TAMs
(Morizono et al., 2011; Meertens et al., 2012). Similarly mutation of the
Gas6 binding residues of Axl inhibits virus uptake by the complex
(Meertens et al., 2012). Thus, the PVEER efﬁcacy of the TAM ligand/
receptor complexes requires both efﬁcient binding of PtdSer by ligand
and binding of ligand by receptor.
Contrary to the TIM family PVEERs where cytoplasmic tail
signaling is not required for enhancing virus entry into cells
(Moller-Tank et al., 2014), signaling through the PTK domain of
TAM receptors is essential for enhancement of viral infection
(Meertens et al., 2012; Bhattacharyya et al., 2013). While the Gas6/
Axl complex is still able to enhance WNV binding and internalization
without kinase activity, subsequent infection is signiﬁcantly impaired
compared to infection of cells expressing WT Axl. This kinase activity
is important in vivo for TAM-receptor-inhibition of DC activation and
inﬂammation (Rothlin et al., 2007; Tibrewal et al., 2008). Ligand
binding by the receptors and assocation with the type I interferon
receptor leads to activation of STAT1 and induction of suppressor of
cytokine signaling (SOCS) proteins (Rothlin et al., 2007). Viruses
appear to utilize this anti-inﬂammatory signaling pathway to dam-
pen the immune response and promote replication (Bhattacharyya
et al., 2013). While TAM signaling is triggered by interaction with
ligand alone, signaling is signiﬁcantly enhanced by the presence of
virus which helps to facilitate the interaction of TAM ligands with
their receptors (Bhattacharyya et al., 2013). Thus, the TAM receptors
enhance virus infection through PVEER functions by enhancing virus
binding and internalization and non-PVEER functions by inhibiting
innate immunity, both of which require binding to PtdSer on the
virion surface and likely contribute to enhancing in vivo virus loads.
MFG-E8/integrin αvβ3 and αvβ5
Milk fat globule-EGF factor 8 (MFG-E8), the most recently identi-
ﬁed PVEER, is a secreted protein that contains two N-terminal EGF
repeats followed by a C1 and C2 domain, of which the latter binds to
PtdSer (Andersen et al., 2000; Ye et al., 2013). Several key positively
charged residues within the C2 domain are responsible for interacting
with the phosphate and serine groups, while hydrophobic residues of
the domain stabilize the positioning of PtdSer (Fig. 1) (Ye et al., 2013).
Like the Gas6, MFG-E8 bridges PtdSer containing membranes to cells
through interaction with a membrane bound protein, either integrin
αvβ3 or αvβ5 (Andersen et al., 2000; Hanayama et al., 2002). This
occurs through an Arg-Gly-Asp (RGD) motif present in the second EGF
Fig. 2. Structures of PtdSer-binding domains. Representative renders of the PtdSer-binding domains of TIM-1/-3/-4, CD300a, RAGE, BAI-1, Gas6/Protein S, Annexin V, MFG-E8,
and Stabilin-1/2 are shown. PtdSer-like ligands (red) and calcium ions (orange) are also displayed for structures with which they were solved. For domains that do not have
solved structures, equivalent domains from other proteins are shown. The IgV domain of TIM-1/-3/-4 is represented by the mTIM-4 IgV domain (2OR8) (Santiago et al., 2007).
The human CD300a IgV domain crystal structure (Dimasi et al., 2007) is shown with residues hypothesized for interaction (Simhadri et al., 2012). The region of the RAGE IgV
domain (3O3U) that corresponds to the binding pockets of CD300a and TIM-1 IgV domains is shown for comparison (Park et al., 2010); however, this domain is only
hypothesized to interact with PtdSer and no residues have been implicated (Friggeri et al., 2011). The thrombospondin type-1 repeats (TSRs) of BAI1 are represented by TSR
domain 3 of human thrombospondin-1 (3R6B) (Klenotic et al., 2011). Gas6 binds PtdSer via a Gla domain, represented by that of bovine prothrombin (1NL2) with residues
identiﬁed that interact with PtdSer (red) (Huang et al., 2003). For AnxV, the structure of one annexin repeat domain from rat Anx V is shown (1A8A) with residues identiﬁed
that interact with PtdSer (red) (Swairjo et al., 1995). The C2 domain of bovine MFG-E8 binds to PtdSer (3BN6) (Shao et al., 2008) and while the structure was not crystallized
with PtdSer, key residues involved in interaction have been determined experimentally (Ye et al., 2013). An EGF-like domain of stabilin-1 or -2 is represented by that from
human heregulin alpha (1HRE) (Nagata et al., 1994).
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repeat of MFGE-8 and mutation of this motif inhibits PVEER efﬁcacy
(Morizono and Chen, 2014).
Several aspects of MFG-E8 biology may contribute to infection.
Similar to the Gas6/Axl complex, MFG-E8/integrin complexes have
been shown to induce production of anti-inﬂammatory cytokines
such as IL-10 (Aziz et al., 2009; Jinushi et al., 2009), some of which
are initiated by activation of STAT-3 (Brissette et al., 2012; Jinushi
et al., 2011). Interestingly, STAT-3 has also been identiﬁed as
an upstream regulator of TIM-1 expression (Ajay et al., 2014).
However, currently MFG-E8 induced signaling activity has not yet
been associated with enhancement of virus entry.
Expression of PVEERs and implications for tropism
The presence of PVEERs in various tissues permissive to infection
may contribute to the tropism of some viruses, particularly for
ﬂaviviruses and ﬁloviruses, whose entries are most enhanced by
PVEER expression. PVEERs are expressed in a variety of tissues and
cell types (summarized in Table 1) that are key targets of infection
by enveloped viruses. TIM-1, TIM-4, and Axl (Li et al., 2013;
Dorfman et al., 2010; Bauer et al., 2012) may enhance uptake of
Dengue virus into Langerhans dendritic cells (DCs), one of the ﬁrst
targets during ﬂavivirus infection (Wu et al., 2000; Marovich et al.,
2001). TIM-1 is also present on the mucosal epithelia of the airway
and eye (Kondratowicz et al., 2011), both of which may be routes of
infection for ﬁloviruses (Jaax et al., 1996). Early during infection,
ﬂaviviruses and ﬁloviruses replicate in antigen-presenting cell
(APC) populations: DCs and macrophages (Geisbert et al., 2003a,
2003b; Jessie et al., 2004). Similarly, alphaviruses infect DCs
(Labadie et al., 2010; Gardner et al., 2000; Nishimoto et al., 2007;
Shabman et al., 2007) and establish persistent infections in macro-
phages (Labadie et al., 2010; Linn et al., 1996). Interestingly, these
APCs express a variety of PVEERs including TIM-4 (Kobayashi et al.,
2007; Rodriguez-Manzanet et al., 2010; Mizui et al., 2008; Meyers
et al., 2005; Baghdadi et al., 2013), TAM receptors (Seitz et al., 2007;
Caraux et al., 2006; Behrens et al., 2003), and MFG-E8/integrin αvβ3
or αvβ5 (Hanayama et al., 2004; Miyasaka et al., 2004; Albert et al.,
1998; Finnemann and Rodriguez-Boulan, 1999; Antonov et al.,
2004). However, little is known about whether these PVEERs play
critical roles in entry of virus into APC populations. Knock out of
TAM receptors from bone marrow-derived DCs signiﬁcantly reduces
infection by West Nile virus or lentiviruses pseudotyped with Ebola,
Marburg, vesicular stomatitis, or murine leukemia virus entry
proteins (Bhattacharyya et al., 2013). In addition, PtdSer liposomes
compete for uptake of EBOV virus-like particles (VLPs) in mouse
peritoneal macrophages (Jemielity et al., 2013). These data suggest
these receptors are relevant for uptake into early infection targets.
PVEERs are also expressed in tissues that are later targets of
virus spread. After infection by ﬂaviviruses, Langerhans cells trafﬁc
to the lymph nodes (Johnston et al., 2000). Once there, ﬂaviviruses
infect lymph node DCs (Balsitis et al., 2009; Kyle et al., 2007),
which have been shown to express TIM-4 (Kobayashi et al., 2007;
Meyers et al., 2005). The alphavirus, Chikungunya virus, and
ﬁloviruses also replicate in lymph nodes (Geisbert et al., 2003a,
2003b; Labadie et al., 2010), where TIM-4, in conjunction with
MFG-E8/integrin αvβ3 and αvβ5 (Hanayama et al., 2004; Garmy‐
Susini et al., 2007), may mediate infection. Infected APCs also
trafﬁc ﬂaviviruses and ﬁloviruses to the liver and spleen, two
major sites of replication (Geisbert et al., 2003a; Jessie et al., 2004;
Balsitis et al., 2009; Baskerville et al., 1985; Bhoopat et al., 1996).
Expression of MFG-E8/integrin αvβ5 and TIM-4 has been detected
in spleen (Meyers et al., 2005; Hanayama et al., 2004; Uehara and
Uehara, 2014). In particular, TIM-4 is expressed on splenic macro-
phages (Kobayashi et al., 2007; Wong et al., 2010), a target of
ﬂaviviruses (Balsitis et al., 2009). TIM-1 and integrin αvβ5 have
been detected on hepatocellular, Huh7-derived cell lines
(Meertens et al., 2012; Kondratowicz et al., 2011) and Kupffer cells
(Wheeler et al., 2001), respectively, and may contribute to ﬂavi-
virus and ﬁlovirus infection of the liver (Geisbert et al., 2003b;
Balsitis et al., 2009; Couvelard et al., 1999; Hall et al., 1991; Xiao et
al., 2001; Ryabchikova et al., 1999). Flaviviruses also infect bone
marrow myeloid cells (Jessie et al., 2004; Balsitis et al., 2009),
which were recently shown to express TIM-4 after stimulation
(Baghdadi et al., 2013).
PVEER expression does not appear to affect the tropism of every
virus for which they enhance entry. For instance, Ross River,
Chikungunya, and Sindbis virus infect muscle cells, which do not
express any currently identiﬁed PVEERs (Morrison et al., 2006;
Johnson, 1965; Ozden et al., 2007), suggesting that either other
unidentiﬁed PVEERs exist or virus entry into muscle cells is
independent of PVEER expression. Interestingly, the PtdSer-
binding receptor BAI1 has been shown to be important for myoblast
fusion (Hochreiter-Hufford et al., 2013). Although BAI1 does not
effectively enhance virus entry in vitro (Meertens et al., 2012), it
may contribute to virus entry in vivo in its native cell type and
environment. This may also be the case for other PtdSer receptors
that do not function as PVEERs in cell culture as the efﬁcacy of these
receptors was assessed after exogenous expression in cell types in
which they are not endogenously expressed. Interestingly, PVEERs
may also not function effectively in every cell population in which
they are endogenously expressed as TIM-1 is present on some
populations of T-cells (Meyers et al., 2005; Umetsu et al., 2005;
Khademi et al., 2004), but, T cells are refractory to EBOV infection
(Wool-Lewis and Bates, 1998). However, this may also be due to
defects in virion internalization machinery or subsequent steps in
the viral life cycle and not PVEER activity. Vaccinia virus does infect
activated T-cells (Chahroudi et al., 2005) and in this case TIM-1 may
contribute to entry. Nonetheless, the effect of PtdSer binding
protein expression on virus tropism has not been thoroughly
explored in tissue culture and, as discussed below, has yet to be
assessed in vivo.
PtdSer-binding proteins without PVEER function
While some PtdSer-binding receptors function effectively as
PVEERs, this is not true for all. Receptor for advanced glycation
end-products (RAGE), brain-speciﬁc angiogensis inhibitor 1 (BAI1),
CD300a, Stabilin-1 and -2, and TIM-3 have all been shown to bind
to phosphatidylserine and enhance engulfment of apoptotic cells
(Fig. 3) (DeKruyff et al., 2010; Hochreiter-Hufford et al., 2013;
Park et al., 2007; He et al., 2011; Friggeri et al., 2011; Nakahashi-
Oda et al., 2012; Simhadri et al., 2012; Park et al., 2008, 2009).
However, expression of these proteins does not enhance virus
entry (Meertens et al., 2012; Moller-Tank et al., 2013; Morizono
and Chen, 2014). Of these proteins, only the mechanism respon-
sible for reduced PVEER efﬁcacy of TIM-3 has been studied. The
inability of TIM-3 to serve as a PVEER is due to the absence of a
MLD stalk of sufﬁcient length (Moller-Tank et al., 2014). However,
this may also explain the reduced efﬁcacy of CD300a that, like
TIM-3, binds PtdSer using an N-terminal IgV-like domain
(Simhadri et al., 2012) and has a short stalk region between its
IgV domain and the transmembrane domain.
Stabilin-1/-2 and BAI1 bind PtdSer through epidermal growth
factor-like (EGF) domain repeats (Park et al., 2009; Kim et al., 2010;
Park et al., 2008) and type 1 thrombospondin repeats (TSRs),
respectively (Park et al., 2007) (Fig. 2), although the residues within
these domains mediating PtdSer binding have yet to be identiﬁed.
While it is unknownwhy these motifs are able to bind apoptotic cells,
but not virions, none of the PtdSer binding receptors that function as
PVEERs bind PtdSer using repeat regions. One explanation may be
that the repeats require a larger or ﬂatter surface area to bind PtdSer
than a virion envelope allows. This biological conundrum requires
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further examination and may provide insight for identiﬁcation of
other PVEERs.
RAGE is the only PtdSer receptor listed above for which the
PtdSer-binding-domain is unidentiﬁed. The extracellular portion
of RAGE consists of an N terminal IgV domain followed by two
IgC2 domains (Fig. 3) (Park et al., 2010). The IgV domain of RAGE
has been suggested to be responsible for PtdSer binding although
this has not yet been experimentally shown (Fig. 2) (Friggeri et al.,
2011). The lack of a similar PtdSer-binding pocket to that of the
CD300a and TIM IgVs and inability to functionally replace the IgV
domain of TIM-1 (SMT, unpublished data) would suggest at least
the IgV domain of RAGE cannot bind to PtdSer on viral envelopes.
Additionally, the condensed structure of the RAGE stalk provided
by the IgC2 domains likely also further reduces PVEER efﬁcacy by
reducing overall length (Moller-Tank et al., 2014). Thus, both the
absence of a clear PtdSer-binding pocket in the IgV domain and
the short stalk likely explain the absent PVEER activity of RAGE.
Mechanism of virus entry enhancement
The key factors required for proteins to function as PVEERs are
PtdSer-binding activity and attachment to the plasma membrane
(Morizono et al., 2011; Meertens et al., 2012; Jemielity et al., 2013;
Moller-Tank et al., 2013). While TIM-1 and TIM-4 individually
perform both functions, the TAM receptors and αvβ3 or αvβ5
integrins provide membrane attachment and their ligands bind to
PtdSer. In the case of the TIM family PVEERs, the spacer domain
between the PtdSer-binding pocket and plasma membrane attach-
ment is a MLD. MLDs from other molecules can substitute for the
TIM MLDs, provided the MLD is of sufﬁcient length, while the
more compact structure of RAGE IgC2 domains is unable to
substitute (Moller-Tank et al., 2014). These studies led us to
propose that an extended structure was needed in the spacer
region, perhaps to extend the PtdSer binding-pocket above the
extracellular matrix that surrounds the cell (Moller-Tank et al.,
2014). Thus, sufﬁcient distance is necessary between the two
essential functions of PVEERs for virus binding.
While we understand how PVEERs bind virus, much less is
currently known about the pathways and/or mechanisms for
PVEER mediated internalization of virus. There is no evidence for
direct internalization. Ebola, baculo-, and vaccinia virus enter
predominantly or at least partially through macropinocytosis
(Mercer and Helenius, 2008; Aleksandrowicz et al., 2011; Nanbo
et al., 2010; Kataoka et al., 2012; Saeed et al., 2010; Mulherkar
et al., 2011) and these viruses are amongst those whose entry is
most signiﬁcantly enhanced by PVEER expression. However, entry
of ﬂaviviruses and alphaviruses is enhanced by PVEER expression,
but primarily occurs through clathrin-mediated endocytosis (Chu
and Ng, 2004; Peng et al., 2009; Acosta et al., 2009; Sourisseau
et al., 2007; DeTulleo and Kirchhausen, 1998; Marsh et al., 1984).
Thus, if PVEERs directly mediate virus internalization, there are
currently no data to support entry via a single pathway. It is
certainly possible that different PVEERs mediate uptake through
different pathways. Alternatively, in some cases, PVEERs may
function only as attachment factors to facilitate interaction of viral
proteins with other cell surface receptors that trigger internaliza-
tion. This may be true for New World arenaviruses that are known
to enter cells using transferrin receptor 1 (Radoshitzky et al., 2007)
and whose entry is only moderately enhanced by PVEER expres-
sion (Jemielity et al., 2013). However, this mechanism does not
account for the ability of PVEERs to stimulate rapid uptake of
viruses lacking a glycoprotein (Moller-Tank et al., 2013; Jemielity
et al., 2013).
Incorporation of PtdSer into viral envelopes
Several viruses have been shown to expose PtdSer on the outer
leaﬂet of their membrane (Soares et al., 2008; Morizono et al.,
2011; Meertens et al., 2012; Moller-Tank et al., 2013). However,
it remains to be determined how PtdSer, which is normally
present within the inner leaﬂet of the cell membrane, is exposed
on the outer leaﬂet of viral membranes. On cellular membranes
the asymmetrical distribution of PtdSer is maintained by the
activity of ﬂippases and ﬂoppases that transfer phospholipids
unidirectionally from either the extracellular side to the cytosolic
side or the reverse, respectively (Leventis and Grinstein, 2010).
Meanwhile, scramblases disrupt asymmetry by mediating random
bidirectional transfer of phospholipids. In healthy cells, exposure
of PtdSer can be induced by several mechanisms, including
apoptosis and elevated levels of intracellular calcium (Leventis
and Grinstein, 2010; Boon and Smith, 2002). Some viruses encode
Fig. 3. PtdSer-binding receptors that do not function as PVEERs. Cartoon representations of Stabilin-1, BAI1, CD300a, RAGE, and TIM-3 are shown. Estimations of N-linked
glycan sites are indicated with blue tridents and O-link glycosylation sites (TIM-3 only) are indicated with a green line. The binding pocket of the RAGE IgV domain is only
hypothesized, as indicated by the presence of a dotted line. Domains for which calcium-binding is necessary for interaction with PtdSer are shownwith calcium ions (orange
spheres).
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proteins that increase cytosolic calcium levels such as Nef of HIV-1
(Manninen and Saksela, 2002) and p7 of hepatitis C virus (Grifﬁn
et al., 2003), reviewed in (Zhou et al., 2009), which may contribute
to PtdSer exposure. Entry of ﬂaviviruses into cells also increases
intracellular calcium levels (Nour et al., 2013). It is also possible
that cellular stresses associated with virus infection trigger apop-
tosis as is seen with inﬂuenza A (Shiratsuchi et al., 2000) and
ﬂaviviruses (Su et al., 2002; Liu et al., 2014; Desprès et al., 1996).
There is evidence that West Nile, Sindbis, and Chikungunya virus
actively activate apoptosis to their advantage (Yang et al., 2008;
Krejbich-Trotot et al., 2011; Levine et al., 1993). In contrast,
however, apoptosis is not induced in cells that are infected by
Ebola viruses (Geisbert et al., 2000; Olejnik et al., 2013), although
internalization of Ebola VLPs and infection of Ebola virus is still
enhanced by TIM-1 expression (Jemielity et al., 2013; Moller-Tank
et al., 2013; Kondratowicz et al., 2011). Further, some viruses for
which entry is enhanced by PVEERs also encode anti-apoptotic
genes, such as NS1 of vaccinia virus (Maluquer de Motes et al.,
2011; Cooray et al., 2007) and P35 of baculovirus (Bertin et al.,
1996). Thus, there is not a clear correlation between induction of
apoptosis and incorporation of PtdSer on viral envelopes.
Viruses may not utilize cellular functions to induce PtdSer
ﬂipping, but rather, concentrate the limited PtdSer present on the
outer leaﬂet. PtdSer may be incorporated into the outer leaﬂet of
viral envelopes during budding for promotion of favorable mem-
brane curvature (Graham and Kozlov, 2010). Alternatively, viruses
may associate with PtdSer in the inner leaﬂet due to its anionic
charge as has been suggested for the matrix proteins of Ebola virus
(Adu-Gyamﬁ et al., 2013) and human immunodeﬁciency virus-1
(Chukkapalli et al., 2013; Vlach and Saad, 2013). The VSV matrix
has also been shown to associate with PtdSer enriched domains
(Luan et al., 1995). Thus, the inner leaﬂet would be enriched with
PtdSer and, after budding, the absence of ﬂippases that normally
regulate PtdSer asymmetry may lead to equilibration of PtdSer
between the outer and inner leaﬂets. Nonetheless, the expression
of the matrix protein alone results in sufﬁcient PtdSer accumula-
tion on the outer leaﬂet of Ebola virus VLPs to allow for TIM-1
enhancement of internalization (Jemielity et al., 2013; Moller-Tank
et al., 2013). These data suggest that regardless of the mechanism,
activity of the matrix protein is sufﬁcient for PtdSer incorporation
into viral envelopes.
Uptake of apoptotic bodies by PVEERs and implications for virus entry
Assuming PVEER enhancement of virus entry occurs through
misrecognition of viruses as apoptotic bodies, it stands to reason
that the pathways of PVEER-mediated virus internalization overlap
with those involved in apoptotic body uptake. Initially it was
believed that apoptotic bodies were internalized through macro-
pinocytosis (Hoffmann et al., 2001; Ogden et al., 2001) which
involves the rufﬂing of membrane to form large cups that engulf
ﬂuid (Swanson, 1989). Macropinocytosis can be stimulated by
receptor signaling induced by a variety of ligands including growth
factors (Racoosin and Swanson, 1989) or PMA (Swanson, 1989).
While spontaneous rufﬂing occurs (Sallusto et al., 1995), only
signaling-induced macropinocytosis leads to complete closure of
the macropinosomes (Li et al., 1997). Contrary to what was
previously thought, studies using SEM revealed that while necrotic
cells are taken up through macropinocytosis, apoptotic bodies are
phagocytosed (Krysko et al., 2006). Unlike macropinocystosis,
which does not speciﬁcally engulf cargo, phagocytosis involves
direct interaction between ligands and receptors. Targets to be
engulfed must be entirely covered in ligand and become enclosed
as binding between receptor and ligand facilitates the binding of
adjacent receptors to ligand (Grifﬁn et al., 1976). This mechanism
is appropriately compared to a zipper (Grifﬁn et al., 1975).
In theory, phagocytosis would best explain the mechanism of
PVEER-mediated internalization with PVEERs sequentially binding
PtdSer on the virion surface. This is particularly ﬁtting for TIM-1-
and TIM-4-mediated internalization of apoptotic bodies, as they
have been shown to form phagocytic cups around cargo (Ichimura
et al., 2008; Wong et al., 2010). However, both PtdSer and VLPs
have been shown to induce macropinocytosis (Aleksandrowicz et
al., 2011; Hoffmann et al., 2001). Additionally, amiloride and its
derivative 5-(N-Ethyl-N-isopropyl) amiloride (EIPA), considered
speciﬁc inhibitors of macropinocytosis (West et al., 1989) and
not phagocytosis (Fukushima et al., 1996), inhibit Ebola virus
uptake into and infection of Vero cells or SNB19 cells that express
TIM-1 and Axl respectively (Kondratowicz et al., 2013; Saeed et al.,
2010; Mulherkar et al., 2011; Hunt et al., 2011). Thus, there exists
disparity between mechanisms of apoptotic body and virus
uptake. Some of this confusion may be attributed to many
components being shared between phagocytosis and macropino-
cytosis. Both require phosphoinositide 3-kinase (PI3K) signaling
(Araki et al., 1996), phospholipase Cγ (Amyere et al., 2000;
Cheeseman et al., 2006), Rac1 (Caron and Hall, 1998; Ridley
et al., 1992), and dynamin (Liu et al., 2008; Cao et al., 2007; Gold
et al., 1999; Tse et al., 2003), making differentiation between the
two processes by targeting components difﬁcult. The only macro-
pinocytosis speciﬁc inhibitor, EIPA, functions by deregulating
intracellular pH and thus may disrupt additional aspects of the
viral life cycle that contribute to inhibition of virus infection
(Koivusalo et al., 2010).
Neither phagocytosis nor macropinocytosis have been studied
in the context of PVEERs. Phagocytosis is associated with phago-
cytic cells such as macrophages and dendritic cells (Rabinovitch,
1995), while all cells can initiate macropinocytosis. It is possible
that both mechanisms are being used and are cell-type dependent.
For example Ebola virus initially infects macrophages and den-
dritic cells, which may occur through phagocytosis, and subse-
quently spreads and enters a broad variety of tissues and cell
types, perhaps by macropinocytosis (Feldmann and Geisbert,
2011). Interestingly, receptors that induce either phagocytosis or
macropinocytosis require phosphorylation and recruitment of
kinases and adapter proteins (Sobota et al., 2005; Swanson,
2008), but several PVEERs have been shown not to require
signaling through cytoplasmic tails for internalization of virus
(Meertens et al., 2012; Moller-Tank et al., 2014; Bhattacharyya
et al., 2013).
Neither phagocytosis nor macropinocytosis of have been shown
to be directly elicited by PVEERs. While Axl has been associated with
macropinocytosis in some cells (Hunt et al., 2011), it is unknown
whether Axl triggers macropinocytosis. There are, however, several
studies that show PtdSer receptors coordinate to induce uptake
signaling. In macrophages there is evidence that Mer induces
internalization of apoptotic bodies, but requires TIM-4 for initial
attachment due to a higher binding afﬁnity for PtdSer (Nishi et al.,
2014). Mer has also been shown to work synergistically with integrin
αvβ5 (Wu et al., 2005). Similarly, TIM-4 and MFG-E8 have been
implicated as partners for uptake of apoptotic bodies in which MFG-
E8/integrin signaling triggers uptake (Toda et al., 2012). Several
details of these mechanisms remain to be elucidated, such as
whether or not TIM-4 actively associates with signaling partners.
TIM-4 has also been shown to interact with adenosine monopho-
sphate activating kinase (AMPK) (Baghdadi et al., 2013), a protein
important for macropinocytosis of Ebola and vaccinia virus
(Kondratowicz et al., 2013; Moser et al., 2010). However, this
interaction is believed to occur after phagocytosis and does not
explain how initial internalization events are triggered. This is also
complicated by evidence that the cytoplasmic tail of TIM-4, the only
domain accessible to AMPK, is unnecessary for internalization (Park
et al., 2009). Further, these mechanisms do not explain why entry of
S. Moller-Tank, W. Maury / Virology 468-470 (2014) 565–580574
viruses that utilize clathrin-coated pits is enhanced by PVEER
expression. Thus, additional studies are required to determine if
and how PVEERs contribute directly to internalization.
Viruses that do not utilize PVEERs
As mentioned above, PVEER expression does not enhance entry
of all enveloped viruses into every cell type. In the case of
arenaviruses, there exists an interesting dichotomy between the
ability of PVEERs to enhance entry of NewWorld but not Old World
arenaviruses. Unlike for ﬁlo-, baculo-, alpha-, vaccinia, and ﬂavi-
viruses, deﬁnitive cellular receptors have been identiﬁed for both
Old World and New World arenaviruses: α-dystroglycan (Cao et al.,
1998) and transferrin receptor 1 (Radoshitzky et al., 2007; Abraham
et al., 2009), respectively. These viruses also use different entry
pathways as New World arenaviruses such as Junín virus enter
using clathrin coated pits (Martinez et al., 2007) while Old World
arenaviruses such as Lassa and lymphocytic choriomeningitis virus
use an unknown pathway that is clathrin, caveolin, and dynamin
independent (Rojek et al., 2008a, 2008b). PVEER-mediated
enhancement of some New World arenaviruses entry into TIM-1
expressing HEK 293T cells is more modest than that found with
ﬁloviruses and ﬂaviviruses, but still signiﬁcant (Jemielity et al.,
2013; Moller-Tank et al., 2013). These New World arenaviruses
can bind to host cells and mediate efﬁcient entry through interac-
tion with transferrin receptor 1, and this can clearly be supplemen-
ted by PVEER expression. For Old World arenaviruses, expression of
and/or afﬁnity to α-dystroglycan may be sufﬁciently robust that
PVEER expression does not notably enhance entry further. Indeed,
in cells lacking α-dystroglycan, other attachment factors, including
Axl, can enhance Old World arenavirus entry (Shimojima et al.,
2012). However, PVEERs are likely not biologically relevant for Old
World arenavirus entry as α-dystroglycan expression is ubiquitous
(Cao et al., 1998; Sullivan et al., 2013).
When carrying its native glycoprotein, entry of VSV is in most
cases, like the Old World arenaviruses, not enhanced by PVEER
expression (Table 1). However, in a few cases we (unpublished
data) and others (Jemielity et al., 2013) have observed a slight
increase in VSV G-mediated entry into cells expressing PVEERs.
The modest effect of PVEER expression on VSV entry is not due to
an absence of PtdSer on the viral envelope as PtdSer can be readily
detected on VSV pseudovirions (Moller-Tank et al., 2013). Instead,
as we propose above for LASV, the utilization by VSV of PVEERs
would be anticipated to be dependent upon the relative avail-
ability of its native receptor. If the native glycoprotein of VSV is
sufﬁcient for optimal virus binding to and entry into cells, PVEER
expression would make little to no contribution to VSV entry.
Entry of SARS corona-, inﬂuenza A, and herpes simplex 1 viruses is
not enhanced by PVEER expression (Meertens et al., 2012; Jemielity
et al., 2013). Inﬂuenza A and SARS-CoV have viral envelope proteins
that bind effectively to sialic acid (Weis et al., 1988) and ACE2 (Li et al.,
2003) respectively. Expression of TIM-1 on HEK 293T cells enhances
internalization of pseudovirions bearing either envelope protein, but
does not result in enhancement of transduction (Jemielity et al., 2013).
These results indicate that PVEER-mediated or -enhanced internaliza-
tion results in unproductive infection by these viruses. This could
occur due to virions being delivered to compartments with incompa-
tible conditions for fusion (i.e. lacking correct pH or fusion triggers). An
alternative possibility is that PVEERs enhance internalization of
defective SARS or inﬂuenza virions with low or negligible levels of
glycoprotein on the viral envelope. These particles would not effec-
tively bind cellular receptors or be able to fuse, and thus their
enhanced internalization would not contribute to infection. Internali-
zation into endosomes may similarly inhibit entry of herpes simplex
virus 1, which fuses at the cell surface (Akhtar and Shukla, 2009).
However, as the effects of PVEER expression on herpes simplex virus
1 internalization have not been tested, it is possible that, in a manner
similar to that proposed for Old World arenaviruses and VSV, strong
association with cellular receptors masks any enhancement. Interest-
ingly in all cases, PVEER overexpression on permissive cells does not
appear to inhibit overall virus entry, suggesting that either a majority
of these viruses either escapes these compartments or enters through
natural productive routes.
In vivo relevance of PVEERs
A major question remaining regarding PVEER-mediated enhance-
ment of virus entry is its relevancy in vivo. The efﬁcacy of PVEERs on
wild-type infectious virus has been demonstrated in vitro with virus
harvested from both cell culture and mice (Jemielity et al., 2013;
Moller-Tank et al., 2013). Additionally, entry of Ebola virus VLPs into
mouse peritoneal macrophages is inhibited by PtdSer liposomes,
providing evidence of PVEER importance for ﬁlovirus entry into
relevant primary cell populations (Jemielity et al., 2013). However, to
date only limited studies have been done in mice to determine the
effect of PtdSer-binding inhibitors and none using PVEER knock
down or knock out. Difﬁculty of testing in vivo relevancy of PVEERs
using knockout mice arises from the potential for compensation by
other PVEERs. Additionally, many PVEERs play critical roles in
regulating adaptive immunity and single or combination knockout
of genes could make interpretation of results difﬁcult and/or lead to
development of autoimmunity (Rodriguez-Manzanet et al., 2010;
Hanayama et al., 2004; Miyanishi et al., 2012; Xiao et al., 2012; Li
et al., 2013). Nonetheless, in a single study, a chimeric antibody that
recognizes PtdSer was shown to inhibit infection by the New World
arenavirus, Pichinde (Soares et al., 2008). Future studies will beneﬁt
from the development of a broad PtdSer-binding inhibitor that can
target multiple PVEERs.
Conclusions
Utilization of PtdSer-binding proteins by viruses to enhance inter-
nalization provides a broad mechanism of viral entry with little
investment by the virus itself. This mechanism may allow some
viruses to attach to cells, thereby making viral glycoprotein/cellular
receptor interactions more probable. Alternatively, other viruses may
rely entirely on PVEERs for internalization into endosomes. This latter
mechanism would eliminate the need of viruses to expose sensitive
viral epitopes extracellularly, thereby protecting critical receptor bind-
ing or membrane fusion motifs from neutralizing antibodies. Once
virions are internalized into endosomes, glycoprotein structural altera-
tions that lead to membrane fusion can occur unhindered by
antibodies. Additionally, the broad expression of PVEERs might con-
tribute to the extensive tropism of viruses such as ﬂaviviruses and
alphaviruses that infect a broad array of insect and mammalian hosts.
Many questions still remain regarding PVEER-mediated entry.
Although there is preliminary evidence as discussed above, the
most important question is what is the in vivo signiﬁcance of
PVEERs and their relative contribution to infection? If PVEER
utilization by viruses in vivo proves to be important, a model for
testing inhibitors of PtdSer binding by PVEERs would be valuable
and could lead to development of a single antiviral or cocktail
capable of inhibiting multiple human viruses. However, as PVEER
expression does not enhance entry of all enveloped virus families,
targeting of PVEERs as an antiviral therapeutic may be limited to
those such as the ﬁloviruses and ﬂaviviruses. Nonetheless, these
viral families include highly pathogenic viruses for which limited
antivirals are available. Second, how is PtdSer being incorporated
into viral envelopes and does it matter which membrane the
envelope is derived from? Third, what is the mechanism
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mediating PVEER-dependent entry? Is there a mechanism of direct
internalization that results in productive infection? Is any cell
signaling involved in these events? Finally, are there additional
unidentiﬁed PVEERs that contribute to this newly appreciated
means of viral infection? This may include potential PtdSer
receptors that have not been tested as PVEERs. CD36, for example,
has been shown to bind oxidized PtdSer for uptake of apoptotic
cells into macrophages (Driscoll et al., 2013; Greenberg et al.,
2006). HEK 293 T cells do not express a detectable amount of the
identiﬁed PVEERs on their surface by surface staining, yet support
low but detectable levels of transduction of ﬁloviruses, ﬂavi-
viruses, and alphaviruses. Certainly one possibility is that there
are additional undiscovered PVEERs mediating entry. Alternatively,
while studies detecting expression of Tyro3 and Mer on HEK 293T
cells have been contradictory, low levels of expression may allow
for entry (Morizono et al., 2011; Bhattacharyya et al., 2013;
Shimojima et al., 2006). Further research on these receptors will
elucidate these gaps in knowledge and determine feasibility of
broad-spectrum antivirals to target them.
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